P. Halcrow

EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER

S Nicholson, P. Halcrow, J R Farndon et al. · The Lancet · 1989 · 218 citations

Breast Oncology, Cancer Growth, Pathology +6

Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup

S Nicholson, J Richard, Christopher Sainsbury et al. · British Journal of Cancer · 1991 · 166 citations · Full text

Breast Oncology, Medicine, Year Follow-up Study +8

Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure

S Nicholson, Christopher Wright, J R C Sainsbury et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1990 · 146 citations

Tamoxifen Failure, Breast Oncology, Medicine +7

Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer

S Nicholson, P. Halcrow, J R C Sainsbury et al. · British Journal of Cancer · 1988 · 114 citations · Full text

Breast Oncology, Primary Endocrine Therapy, Medicine +7